I4. New vaccines
Poster Session: New Vaccines
Edward E. Walsh, MD (he/him/his)
Professor of Medicine
University of Rochester
Rochester, NY, United States
John Woodside, PhD
Clinical Scientist
Pfizer
London, England, United Kingdom
Gonzalo Perez Marc, MD
CEO
i-trials
Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina
Daniel P. Eiras, MD, MPH
Associate Director
Pfizer, Inc.
Pearl River, New York, United States
Qin Jiang, PhD
Senior Director
Pfizer
Collegeville, Pennsylvania, United States
Conrado J. Llapur, MD
Hospital del Niño Jesús
San Miguel de Tucuman, Tucuman, Argentina
Yasushi Fukushima, MD PhD
Fukuwa clinic
Chuo-ku, Tokyo, Japan
Mika Rämet, MD, PhD
Tampere University
Tampere, Pirkanmaa, Finland
Louis J Bont, M.D.
Paediatric Immunology and Infectious Diseases
University Medical Centre Utrecht
Utrecht, Utrecht, Netherlands
Nazreen Hussen, MD
Netcare Lakeview Hospital
Benoni, Gauteng, South Africa
Tarek Mikati, MD,MPH (he/him/his)
Associate Medical Director
3. Pfizer, Inc., Vaccine Research & Development
Pearl River, New York, United States
Michael Patton, B.Sc.
Pfizer, Vaccine Research and Development
Hurley, England, United Kingdom
Agnieszka Zareba, MD PhD
Director Vaccines Research
Pfizer
Pearl RIver, New York, United States
Kumar Ilangovan, MD, MSPH, MMCi (he/him/his)
Director, Clinician Medical Monitor
Vaccine Research and Development, Pfizer, USA
Raleigh, North Carolina, United States
Maria Maddalena Lino, PhD
Pfizer
Siena, Toscana, Italy
Elena Kalinina, PhD
Director
Pfizer
Pearl River, New York, United States
David Cooper, PhD
Senior Director
Pfizer
Pearl River, New York, United States
Kena A. Swanson, Ph.D.
Vice President, Viral Vaccines
Pfizer
Pearl River, New York, United States
Annaliesa S. Anderson, PhD
SVP & CSO
Pfizer
New York, New York, United States
Alejandra C. Gurtman, M.D.
Vice President
Pfizer
Pearl River, New York, United States
Iona Munjal, MD (she/her/hers)
Executive Director
Pfizer Inc, United States